Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
 
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve
Pubget Overpricing |  
lüll
Systemic vasculitis treatment and monitoring update, 2008 Yazici YBull NYU Hosp Jt Dis 2008[]; 66 (3): 228-30Vasculitic syndromes are among the most complicated diseases for primary care physicians and rheumatologists to diagnose and treat. There are a myriad of symptoms that can be mimicked by other conditions, and choice of medications can be complex. Some agents are toxic and determining which to prescribe and for how long can be a multifaceted, complex decision process. Developing new treatments and new ways of using already available therapies, while minimizing potential side effects, are of paramount importance. This review will focus on recently published data that could have an impact on the way we treat systemic vasculitis patients.|Antibodies, Antineutrophil Cytoplasmic/blood[MESH]|Biomarkers/blood[MESH]|Cyclophosphamide/therapeutic use[MESH]|Etanercept[MESH]|Humans[MESH]|Immunoglobulin G/therapeutic use[MESH]|Immunoglobulins, Intravenous/therapeutic use[MESH]|Immunosuppressive Agents/adverse effects/*therapeutic use[MESH]|Methotrexate/therapeutic use[MESH]|Practice Guidelines as Topic[MESH]|Receptors, Tumor Necrosis Factor/therapeutic use[MESH]|Remission Induction[MESH]|Treatment Outcome[MESH]|Vasculitis/*diagnosis/immunology/*therapy[MESH] |
